Ledyard National Bank Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Ledyard National Bank grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,403 shares of the healthcare conglomerate’s stock after purchasing an additional 78 shares during the period. Ledyard National Bank’s holdings in UnitedHealth Group were worth $8,636,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bensler LLC grew its position in UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after buying an additional 19 shares during the period. Texas Capital Bancshares Inc TX lifted its position in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares in the last quarter. Tealwood Asset Management Inc. raised its position in UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after acquiring an additional 19 shares during the period. Atlas Private Wealth Advisors increased its stake in shares of UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after purchasing an additional 19 shares in the last quarter. Finally, Prentice Wealth Management LLC boosted its holdings in UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after buying an additional 19 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Truist Financial restated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Piper Sandler increased their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Finally, Barclays lifted their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Stock Down 1.3 %

Shares of UnitedHealth Group stock traded down $6.35 during trading hours on Monday, hitting $489.00. The company had a trading volume of 2,192,486 shares, compared to its average volume of 4,479,956. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a market cap of $449.92 billion, a P/E ratio of 29.89, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. The company’s 50-day moving average is $485.19 and its two-hundred day moving average is $513.81.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the firm posted $6.26 EPS. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. Analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.54%. UnitedHealth Group’s payout ratio is currently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.